TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34740705

Group type: EXPERIMENTAL
Intervention: EDP-305 2.5 mg
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: EDP-305 1 mg
Number of subjects: 134

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 134
Study: 34507557

Group type: EXPERIMENTAL
Intervention: WHO Safe Childbirth Checklist (WHO-SCC) implemented in intervention facilities with training and supportive supervision
Number of subjects: 2530

Group type: COMPARATOR
Intervention: Standard of care in control group
Number of subjects: 2530

Group type: EXPERIMENTAL
Intervention: Direct observations of healthcare providers' adherence to evidence best practices
Number of subjects: 2530
Study: 35227405

Group type: EXPERIMENTAL
Intervention: Cognitive Bias Modification for Interpretation (CBM‐I)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Psychoeducation
Number of subjects: 31
Study: 32005090

Group type: EXPERIMENTAL
Intervention: Statistically significant findings (P<.05) reported across 44 trials
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Statistically significant results with FPR greater than 5%
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Statistically significant results with FPR greater than 50%
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Changing prior probability from skeptical to optimistic
Number of subjects: 62
Study: 33823377

Group type: EXPERIMENTAL
Intervention: Therapeutic dose of pyridoxine (pyridoxine group, 46 of 105, 44%)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Homeopathic dose of pyridoxine (placebo, 59 of 105, 56%)
Number of subjects: 105
Study: 32476164

Group type: EXPERIMENTAL
Intervention: Group intervention (n = 40); eight weekly 1.5-hour sessions
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Guided self-help (GSH) intervention (n = 31); self-study with eight weekly 20-minute phone calls
Number of subjects: 71
Study: 36334113

Group type: EXPERIMENTAL
Intervention: Imagery rescripting (ImRs)
Number of subjects: 100

Group type: COMPARATOR
Intervention: No-intervention control (NIC)
Number of subjects: 100
Study: 33675398

Group type: EXPERIMENTAL
Intervention: Paraffin bath + splint + exercise
Number of subjects: 51

Group type: COMPARATOR
Intervention: Splint + exercise therapy
Number of subjects: 51
Study: 32556371

Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (a-tDCS) 1 mA for 20 min over the primary motor cortex (M1) for 5 consecutive days
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sham stimulation (tDCS device turned off after 30 s)
Number of subjects: 32
Study: 35979930

Group type: EXPERIMENTAL
Intervention: Cartiva intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alternative scenario 1 (eliminating failures based solely upon radiographs findings)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alternative scenario 2 (considering only major surgical revision as a failure)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alternative scenario 3 (using VAS pain threshold of <30 as success criterion)
Number of subjects: 0
Study: 34620621

Group type: EXPERIMENTAL
Intervention: 5 mg ertugliflozin
Number of subjects: 1776

Group type: EXPERIMENTAL
Intervention: 15 mg ertugliflozin
Number of subjects: 1776

Group type: EXPERIMENTAL
Intervention: ertugliflozin
Number of subjects: 1776
Study: 32784372

Group type: EXPERIMENTAL
Intervention: Energy drink (140 mg of caffeine)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Energy drink
Number of subjects: 17
Study: 36523503

Group type: EXPERIMENTAL
Intervention: Ultrasound (US) guidance
Number of subjects: 19

Group type: COMPARATOR
Intervention: Electrical stimulation (E-stim) guidance
Number of subjects: 19
Study: 35419064

Group type: EXPERIMENTAL
Intervention: Aripiprazole plus Topiramate (Group 1, n = 15)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Aripiprazole (Group 2, n = 14)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Both groups (Group 1 and Group 2)
Number of subjects: 29
Study: 33835886

Group type: EXPERIMENTAL
Intervention: Itolizumab (Arm-A)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Best Supportive Care (Arm-B)
Number of subjects: 31
Study: 32035361

Group type: EXPERIMENTAL
Intervention: Ecc-BFR
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Con-BFR
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control
Number of subjects: 36
Study: 36015021

Group type: EXPERIMENTAL
Intervention: Endobronchial valves (EBVs) implantation
Number of subjects: 35
Study: 33029934

Group type: EXPERIMENTAL
Intervention: Mevidalen (LY3154207) 25-200 mg (SAD study)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mevidalen (LY3154207) 15-150 mg once-daily for 14 days (MAD study)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 33849723

Group type: EXPERIMENTAL
Intervention: EuTCV (Vi-CRM197)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Typbar-TCV® (WHO prequalified vaccine)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Typhim Vi® (Vi polysaccharide vaccine)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: EuTCV and Typbar-TCV®
Number of subjects: 75

Group type: COMPARATOR
Intervention: Typhim Vi®
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: EuTCV
Number of subjects: 75
Study: 35396071

Group type: EXPERIMENTAL
Intervention: Active taVNS
Number of subjects: 15

Group type: COMPARATOR
Intervention: Sham taVNS
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: taVNS current ≥2.5 mA (subanalysis of 8 participants)
Number of subjects: 15
Study: 32527270

Group type: EXPERIMENTAL
Intervention: Enhanced primary care plus contextually-tailored health coaching
Number of subjects: 721

Group type: COMPARATOR
Intervention: Enhanced primary care
Number of subjects: 721
Study: 34618979

Group type: EXPERIMENTAL
Intervention: Heavy-load power-oriented resistance training (HL-PT, 80% 1-RM)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Light-load power-oriented resistance training (LL-PT, 40% 1-RM)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Both HL-PT and LL-PT
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Light-load power-oriented resistance training (LL-PT)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Heavy-load power-oriented resistance training (HL-PT)
Number of subjects: 45
Study: 33885395

Group type: EXPERIMENTAL
Intervention: Powered toothbrush
Number of subjects: 0

Group type: COMPARATOR
Intervention: Manual toothbrush
Number of subjects: 0
Study: 33289785

Group type: EXPERIMENTAL
Intervention: ACT on Health program plus weekly phone coaching
Number of subjects: 79

Group type: COMPARATOR
Intervention: Waitlist
Number of subjects: 79
Study: 32028385

Group type: EXPERIMENTAL
Intervention: Intensive patients' education program (IEP)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group (usual care only)
Number of subjects: 180
Study: 35339761

Group type: EXPERIMENTAL
Intervention: MNmask v1
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: MNmask v2
Number of subjects: 38
Study: 32979515

Group type: EXPERIMENTAL
Intervention: Remote physical activity intervention (RGV)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual care enhanced with caregiver support (EUC)
Number of subjects: 100
Study: 35834180

Group type: EXPERIMENTAL
Intervention: Nonalcoholic beer (0.0% v/v)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Alcoholic beer (5.2% v/v)
Number of subjects: 22
Study: 36028881

Group type: EXPERIMENTAL
Intervention: Pursed lip breathing exercise and inhaler training
Number of subjects: 67

Group type: COMPARATOR
Intervention: Inhaler training only
Number of subjects: 67
Study: 32998761

Group type: EXPERIMENTAL
Intervention: Cooled dialysate (temperature 35 °C)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Standard care (dialysate temperature 36.5 °C)
Number of subjects: 90
Study: 34982866

Group type: EXPERIMENTAL
Intervention: Prolonged exposure (PE) therapy for PTSD
Number of subjects: 4
Study: 34675477

Group type: EXPERIMENTAL
Intervention: Dexamethasone intravitreal implant 0.7 mg (DEX) every 5 months
Number of subjects: 284

Group type: COMPARATOR
Intervention: Laser photocoagulation every 3 months as needed
Number of subjects: 284
Study: 34924506

Group type: EXPERIMENTAL
Intervention: Ciprofol
Number of subjects: 39

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 39
Study: 33314313

Group type: EXPERIMENTAL
Intervention: Active vibration therapy (30 Hz and 0.3 g)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 34814113

Group type: EXPERIMENTAL
Intervention: DEC (fast start followed by decreasing speed)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: VAR (systematic variation in exercise intensity)
Number of subjects: 10

Group type: COMPARATOR
Intervention: CON (constant speed)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: DEC and VAR
Number of subjects: 10

Group type: COMPARATOR
Intervention: DEC, VAR, and CON
Number of subjects: 10
Study: 32246224

Group type: EXPERIMENTAL
Intervention: TAS-114/S-1 (TAS-114 400 mg and S-1 30 mg/m2)
Number of subjects: 127

Group type: COMPARATOR
Intervention: S-1 (S-1 30 mg/m2)
Number of subjects: 127
Study: 33579655

Group type: EXPERIMENTAL
Intervention: Video laryngoscope
Number of subjects: 70

Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 70
Study: 32396409

Group type: EXPERIMENTAL
Intervention: Bag squeeze (group A)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Sham bag squeeze (group B)
Number of subjects: 190
Study: 34619143

Group type: EXPERIMENTAL
Intervention: PVI with PWI
Number of subjects: 338

Group type: COMPARATOR
Intervention: PVI alone
Number of subjects: 338
Study: 34499157

Group type: EXPERIMENTAL
Intervention: 6-week exercise program combined with active PBMT (n=45)
Number of subjects: 90

Group type: COMPARATOR
Intervention: 6-week exercise program combined with placebo PBMT (n=45)
Number of subjects: 90
Study: 35057755

Group type: EXPERIMENTAL
Intervention: Tablet-assisted motivational counselling at the participant's home and two follow-up telephone sessions
Number of subjects: 254

Group type: COMPARATOR
Intervention: Postal general health information
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Tablet-assisted motivational counselling
Number of subjects: 254
Study: 34222044

Group type: EXPERIMENTAL
Intervention: HA-L vaccine
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: HA-I vaccine
Number of subjects: 120
Study: 32282927

Group type: EXPERIMENTAL
Intervention: Endovascular treatment (EVT) performed by trained general interventional radiologists
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Endovascular treatment (EVT) with stent retrievers introduced in 2011
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Endovascular treatment (EVT) with aspiration and stent retrievers introduced in 2012
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Endovascular treatment (EVT) in 2018
Number of subjects: 235
Study: 33142340

Group type: EXPERIMENTAL
Intervention: Enrolled subjects in the PREMOD2 trial
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sites with waiver of consent
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Infants approached for consent prior to delivery
Number of subjects: 0
Study: 33480518

Group type: EXPERIMENTAL
Intervention: CON (concentric-only)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: ECC (eccentric-only)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: CON-ECC (alternated concentric followed by eccentric)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: ECC-CON (alternated eccentric followed by concentric)
Number of subjects: 12

Group type: COMPARATOR
Intervention: CON-ECC
Number of subjects: 12
Study: 34773094

Group type: EXPERIMENTAL
Intervention: ONS (2.510 MJ)
Number of subjects: 21

Group type: COMPARATOR
Intervention: PLACEBO (0.377 MJ)
Number of subjects: 21
Study: 33247344

Group type: EXPERIMENTAL
Intervention: Amoxicillin for 3 months
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo for 3 months
Number of subjects: 180
Study: 33621631

Group type: EXPERIMENTAL
Intervention: High-frequency spinal cord stimulation (SCS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Burst spinal cord stimulation (SCS)
Number of subjects: 0
Study: 35720883

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided nerve block anesthesia + comprehensive nursing based on blind deblurring algorithm
Number of subjects: 50

Group type: COMPARATOR
Intervention: Tracheal intubation intravenous anesthesia + routine nursing
Number of subjects: 50
Study: 34127559

Group type: COMPARATOR
Intervention: Pill splitting using own technique (Group A)
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Pill splitting using pill cutters after training (Group B)
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Pill splitting training (Group B)
Number of subjects: 193
Study: 35845953

Group type: EXPERIMENTAL
Intervention: Sevoflurane-desflurane group (Group-SD)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sevoflurane-only group (Group-S)
Number of subjects: 60
Study: 33293172

Group type: EXPERIMENTAL
Intervention: Topical Dexamethasone
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Intravenous Dexamethasone
Number of subjects: 90
Study: 33826431

Group type: EXPERIMENTAL
Intervention: Good adherence to DMTs
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Poor adherence to DMTs
Number of subjects: 142

Group type: COMPARATOR
Intervention: Non-adherence to DMTs
Number of subjects: 142
Study: 33487564

Group type: EXPERIMENTAL
Intervention: Tactile, kinesthetic and oral stimulation (T + K + OS)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Oral stimulation (OS)
Number of subjects: 42
Study: 33567018

Group type: EXPERIMENTAL
Intervention: Multifocal SN6AD1 IOL
Number of subjects: 38

Group type: COMPARATOR
Intervention: Aspheric monofocal SN60WF IOL
Number of subjects: 38
Study: 34459448

Group type: EXPERIMENTAL
Intervention: Combined enhanced instruction
Number of subjects: 311

Group type: COMPARATOR
Intervention: Telephone reeducation
Number of subjects: 311

Group type: COMPARATOR
Intervention: Control
Number of subjects: 311
Study: 33655429

Group type: EXPERIMENTAL
Intervention: Mothers and Babies delivered via home visiting paraprofessionals
Number of subjects: 874

Group type: EXPERIMENTAL
Intervention: Mothers and Babies delivered via mental health professionals
Number of subjects: 874

Group type: COMPARATOR
Intervention: Usual community-based services (control)
Number of subjects: 874
Study: 33046213

Group type: EXPERIMENTAL
Intervention: 400 mg of the dopaminergic antagonist amisulpride
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: 50 mg of the opioidergic antagonist naltrexone
Number of subjects: 131

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 131
Study: 35657611

Group type: EXPERIMENTAL
Intervention: Disease Modifying Anti-Rheumatic Drugs (DMARDs)
Number of subjects: 69
Study: 34369680

Group type: EXPERIMENTAL
Intervention: Warm-needle moxibustion (WNM)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control (medication)
Number of subjects: 84
Study: 35916933

Group type: EXPERIMENTAL
Intervention: 2+2 night shift (two consecutive night shifts followed by two consecutive recovery days)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: 4+4 night shift (four consecutive night shifts followed by four consecutive recovery days)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: 7+7 night shift (seven consecutive night shifts followed by seven consecutive recovery days)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Night shifts
Number of subjects: 17

Group type: COMPARATOR
Intervention: Recovery days
Number of subjects: 17
Study: 34117080

Group type: EXPERIMENTAL
Intervention: Severe AKI
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Stage 3 AKI
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Stage 3 AKI occurring 7 days before death
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Intraventricular hemorrhage
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Sepsis
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Severe AKI occurring 7 days before death
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Late severe AKI (after day 14 and before day 28)
Number of subjects: 900
Study: 32456048

Group type: EXPERIMENTAL
Intervention: Plyometric exercise
Number of subjects: 14

Group type: COMPARATOR
Intervention: Ankle stability exercise
Number of subjects: 14
Study: 35944602

Group type: EXPERIMENTAL
Intervention: Interdisciplinary pain management program (3-week intervention)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Usual care (TAU)
Number of subjects: 103
Study: 36129364

Group type: EXPERIMENTAL
Intervention: Walk 'n Watch protocol
Number of subjects: 195

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 195
Study: 32563863

Group type: EXPERIMENTAL
Intervention: DHA-enriched fish oil (FO) 2 g/day (860 mg DHA + 120 mg EPA)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Corn oil (CO) 2 g/day
Number of subjects: 73
Study: 35440345

Group type: EXPERIMENTAL
Intervention: Mass Prolonged Exposure (MPE) therapy
Number of subjects: 138

Group type: COMPARATOR
Intervention: Standard Prolonged Exposure (SPE) therapy
Number of subjects: 138
Study: 33904589

Group type: EXPERIMENTAL
Intervention: Adherence to attachment‐based family therapy (ABFT)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Adherence to family‐enhanced nondirective supportive therapy (FE‐NST)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Adherence to attachment‐based family therapy (ABFT) with therapeutic alliance as a moderator
Number of subjects: 118

Group type: COMPARATOR
Intervention: Adherence to family‐enhanced nondirective supportive therapy (FE‐NST) with therapeutic alliance as a moderator
Number of subjects: 118
Study: 33403819

Group type: EXPERIMENTAL
Intervention: Complementary feeding behaviour change communication for 9 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 35916749

Group type: EXPERIMENTAL
Intervention: Warm-up with core stability exercises (CORE)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Warm-up with elastic band exercises (ELAS)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Traditional warm-up (TRAD)
Number of subjects: 15
Study: 34429646

Group type: EXPERIMENTAL
Intervention: Lidocaine topical system 1.8% under swimming conditions
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Lidocaine topical system 1.8% under showering conditions
Number of subjects: 24

Group type: COMPARATOR
Intervention: Lidocaine topical system 1.8% under normal conditions
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Lidocaine topical system 1.8%
Number of subjects: 24
Study: 32293533

Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (n = 40)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Active control condition based on physical training (n = 40)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Treatment as usual (TAU) control group (n = 40)
Number of subjects: 120
Study: 35347080

Group type: EXPERIMENTAL
Intervention: Automated continuous monitoring alert to initiate RT driven care
Number of subjects: 201

Group type: COMPARATOR
Intervention: Standard RT assessment tool
Number of subjects: 201
Study: 34313875

Group type: EXPERIMENTAL
Intervention: Communication-focused grants
Number of subjects: 344
Study: 32535601

Group type: EXPERIMENTAL
Intervention: Combined physical movement activity and multifaceted cognitive training (24 sessions, twice a week)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 70
Study: 34536637

Group type: EXPERIMENTAL
Intervention: Liquid sugars (total liquid sugar, liquid glucose, liquid fructose, fructose from fruit juice)
Number of subjects: 7056

Group type: EXPERIMENTAL
Intervention: Liquid sugars
Number of subjects: 7056
Study: 33965876

Group type: EXPERIMENTAL
Intervention: Self-Regulated Learning
Number of subjects: 40

Group type: COMPARATOR
Intervention: Activity-Based intervention
Number of subjects: 40
Study: 32345760

Group type: EXPERIMENTAL
Intervention: VPes‐guided (PEEP tailored to equalize end‐expiratory transpulmonary pressure)
Number of subjects: 28
Study: 36136436

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI)
Number of subjects: 302

Group type: COMPARATOR
Intervention: Printed literature (control)
Number of subjects: 302
Study: 33663889

Group type: EXPERIMENTAL
Intervention: Caregiver Assistance Scale scores and patient age
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Caregiver gender and smoking status
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Caregiver age
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Time (post‐surgery vs pre‐surgery)
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Patient body mass index, patient and caregiver gender
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Patient and caregiver employment status and caregiver education level
Number of subjects: 306
Study: 32909356

Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation (FMT) by washed preparation
Number of subjects: 9
Study: 35331700

Group type: EXPERIMENTAL
Intervention: Bupivacaine (with epinephrine 0.25%, 1:200,000)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Liposomal Bupivacaine (LipoB) 1.3%
Number of subjects: 50
Study: 32931950

Group type: EXPERIMENTAL
Intervention: Basophil activation test (BAT) using shrimp extract as stimulant
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: EXiLE test with shrimp extract and tropomyosin
Number of subjects: 35

Group type: COMPARATOR
Intervention: Skin prick test (SPT)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Serum specific IgE (sIgE)
Number of subjects: 35
Study: 33438008

Group type: EXPERIMENTAL
Intervention: Ozanimod HCl 1 mg daily
Number of subjects: 197

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 197
Study: 36326985

Group type: EXPERIMENTAL
Intervention: Morning exercise (AMEx; 0600-0900)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Evening exercise (PMEx; 1600-1900)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 100
Study: 33981097

Group type: EXPERIMENTAL
Intervention: Topical anaesthesia
Number of subjects: 702

Group type: COMPARATOR
Intervention: Peribulbar anaesthesia
Number of subjects: 702
Study: 35195913

Group type: EXPERIMENTAL
Intervention: Intravenous liposomal irinotecan at 70 mg/m2
Number of subjects: 25
Study: 33813009

Group type: EXPERIMENTAL
Intervention: Hydrogen peroxide application to the dermis
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard skin preparation and antibiotic prophylaxis (Control)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Both groups (Hydrogen peroxide and Control)
Number of subjects: 60